[Home ] [Archive]    
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
Contact us::
Site Facilities::
Webmail::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 13, Issue 3 (Aug & sept 2008 2008) ::
pajoohande 2008, 13(3): 239-245 Back to browse issues page
Plasma Levels of the NT- Pro BNP in Patients Presenting with Heart Failure
Pour Piranfar MA * , Pordal AH , Mashayekh Bakhshi F , Hedayati M , Beiranvand MR , Ali Asgari A , Katouzian B
, drpiranfar@yahoo.com
Abstract:   (14675 Views)
Background: In view of the high morbidity and mortality of patients with congestive heart failure, early diagnosis is of paramount importance. To assess the diagnostic and prognostic utility of plasma levels of the NT- Pro BNP in patients presenting with heart failure this study was carried out. Materials and Methods: This cross-sectional study was performed on patients with heart failure admitted in the cardiology ward of Taleghani Medical Center during a certain period from 2005- 2006. Subjects with acute coronary syndrome, hyperthyroidism, renal failure (GFR< 60), severe valvular stenosis, severe pulmonary disease, ARDS, hepatic cirrhosis, primary hyperaldosteronism and the candidates for heart transplant were excluded from the study. Blood samples were collected and plasma levels of NT-Pro BNP were measured by ELISA method (Biomedica- crop, Bratislava Slovakia). Results were documented and analyzed using SPSS software. Mann- Whitheny and KrusKall-Wallis tests were utilized for analysis. Values were analyzed for confounding variables (e.g age, sex, blood pressure, ischemic heart disease and NYHA class). Results: 79 patients full filled the criteria of inclusion. 70% were males and mean age of patients was 63  14 years. Mean plasma NT-Pro BNP level was 421  387. In subjects < 60 years of age, the mean levels were 309  300, and among those 60 years it was 486 419, (P< 0.05). With advancing clinical stage, the mean plasma level of NT-Pro BNP increased 6 folds, ( P< 0.01 ), whereas with advancing NYHA class it increased 4 folds ( P< 0.01). Conclusion: It seams that plasma NT- Pro BNP level is a suitable indicators of the severity of heart failure.
Keywords: Pro-Brain Natriuretic Peptide (NT-Pro BNP), BNP, Congestive heart failure, NYHA class, Clinical stage, LVEF
Full-Text [PDF 133 kb]   (4181 Downloads)    
Type of Study: Original | Subject: Medicine
Received: 2017 | Accepted: 2017 | Published: 2017
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Pour Piranfar MA, Pordal AH, Mashayekh Bakhshi F, Hedayati M, Beiranvand MR, Ali Asgari A et al . Plasma Levels of the NT- Pro BNP in Patients Presenting with Heart Failure . pajoohande 2008; 13 (3) :239-245
URL: http://pajoohande.sbmu.ac.ir/article-1-639-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 13, Issue 3 (Aug & sept 2008 2008) Back to browse issues page
Persian site map - English site map - Created in 0.05 seconds with 36 queries by YEKTAWEB 4645